Researchers from the British Columbia Cancer Agency, the University of British Columbia, and elsewhere uncovered an abundance of known and novel microRNAs in diffuse large B-cell lymphoma through sequencing fresh or formalin-fixed, paraffin-embedded samples. As they report in Genome Biology, the set included half a dozen miRNAs that appeared to show significant ties to patient outcomes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.